Format

Send to

Choose Destination
See comment in PubMed Commons below
Leukemia. 2014 Sep;28(9):1918-22. doi: 10.1038/leu.2014.152. Epub 2014 May 5.

Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2.

Author information

1
Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
2
1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA [2] Gerstner Sloan-Kettering Graduate School in Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
3
Department of Biomedical Science, Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna (VUV), Vienna, Austria.
4
Center for Physiology and Pharmacology, Medical University of Vienna (MUV), Vienna, Austria.
5
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
6
Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.
7
Eppley Institute for Research in Cancer and Allied Diseases, 985950 Nebraska Medical Center, Omaha, NE, USA.
8
1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA [2] Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
PMID:
24791858
PMCID:
PMC4158830
DOI:
10.1038/leu.2014.152
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center